Founded in 2019 and headquartered in La Jolla, California, Iambic is disrupting the therapeutics landscape with its cutting-edge generative AI drug discovery platform. We have assembled a world-class team that unites pioneering AI experts and seasoned drug hunters with strong track records of success in delivering clinically validated breakthrough treatments. The Iambic platform has been demonstrated to deliver high-quality, differentiated drugs to clinics with unprecedented speed and across multiple targets and mechanisms of action. We are focused on the advancement of our internal pipeline of clinical assets to address urgent unmet patient needs in oncology and other therapeutic areas.
The culture and work at Iambic are profoundly strengthened by the diversity of our people and our differences in background, culture, national origin, religion, sexual orientation, and life experiences. We are committed to building an inclusive environment where a diverse group of talented humans work together to discover therapeutics and create technologies.